Zobrazeno 1 - 10
of 3 889
pro vyhledávání: '"Booster dose"'
Autor:
Gilbert Eshun, Frank Kyei-Arthur, Marwa Shawky Abdou, Martin Wiredu Agyekum, Michael Sarfo, John Kwame Agbenyeavu, Sylvia Agyeman Addai, Jeremiah Akuffo Adjei, Nelson Obeng, Justice Kwadwo Turzin, Ramy Mohamed Ghazy
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background The Health Belief Model (HBM) is a widely utilised framework for understanding vaccination behaviour against COVID-19. This study assessed the acceptance of COVID-19 vaccine booster doses in Ghana and identified predictors using H
Externí odkaz:
https://doaj.org/article/7a897caac6674f3ab3babe31daefd338
Autor:
Archin Songthap, Kanamas Sesang, Chanikan Ratchaphan, Thanachaporn Luangkhan, Phattaraporn Jenjob
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Coronavirus disease 2019 (COVID-19) causes more deaths in older adults than in younger adults. Older adults are a vulnerable group with a high need for coronavirus vaccines to decrease the severity of the disease. The aim of this
Externí odkaz:
https://doaj.org/article/61db0455404a442590e98a9cb8c10c58
Publikováno v:
Nigerian Journal of Paediatrics, Vol 36, Iss 3 & 4, Pp 87-90 (2024)
Background: Vaccine preventable diseases still account for a large proportion of childhood morbidity and mortality in children less than five of age. The decline in immunization coverage over the years has worsened this resulting in the re-emergence
Externí odkaz:
https://doaj.org/article/e47aac2306e641fcbd746ddf3396c43b
Publikováno v:
Clinical Epidemiology and Global Health, Vol 30, Iss , Pp 101785- (2024)
Background: Despite the proven therapeutic potential of bivalent vaccine primer doses against COVID-19, acceptance of vaccine booster doses (VBDs) varies among various subgroups of the global population. This study investigated the acceptance of COVI
Externí odkaz:
https://doaj.org/article/803639e74acc419986aa02b0ec825268
Autor:
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, Lakkhana Wongsrisang, Ratchadawan Aeemjinda, Preeyaporn Vichaiwattana, Thaksaporn Thatsanathorn, Warangkana Chantima, Pattarakul Pakchotanon, Thaneeya Duangchinda, Natthinee Sudhinaraset, Sittisak Honsawek, Yong Poovorawan
Publikováno v:
Vaccine: X, Vol 20, Iss , Pp 100538- (2024)
This cohort study, conducted between July and August 2023, evaluated the adverse events (AEs) and immune response to a bivalent mRNA-1273.222 (containing sequences of the original Wuhan-H1 strain and the Omicron BA.4/5 variant) booster vaccine in 122
Externí odkaz:
https://doaj.org/article/9a940731606d476eb226f6c3ad7ed675
Publikováno v:
Journal of Pharmacy and Bioallied Sciences, Vol 16, Iss 6, Pp 1776-1783 (2024)
BackgroundNew severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and waning vaccine efficacy led to the administration of booster doses. Healthcare workers (HCWs) are vulnerable to contract the infection, and vaccination hesitancy
Externí odkaz:
https://doaj.org/article/ce0c97cd647149c5bcb4603a59e358c0
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract SARS-CoV-2 lipid nanoparticle mRNA vaccines continue to be administered as the predominant prophylactic measure to reduce COVID-19 disease pathogenesis. Quantifying the kinetics of the secondary immune response from subsequent doses beyond t
Externí odkaz:
https://doaj.org/article/97ea8cf166b64a3aba79899af41aa2a2
Autor:
Bertin Mindje Kolomba, Francois Kalenga Luhembwe, Deca Blood Banza Ndala, Pacifique Kanku Wa Ilunga, Paul Ciamala Mukendi, Amide Ngongo Kitenge, John Ngoy Lumbule, Elie Kilolo Ngoy, Antoine Umba Ilunga, Judith Mbidi Miema, Christelle Kalikat Mwavita, Guillaume Ngoy Mwamba, Aime Cikomola Wa Bene, Audry Mulumba Wakamba, Alain Ngashi Ngongo, Michel Kabamba Nzaji
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThe COVID-19 booster dose is considered an important adjunct for the control of the COVID-19 pandemic due to reports of reduced immunity in fully vaccinated individuals. The aims of this study were to assess healthcare workers’ intention to
Externí odkaz:
https://doaj.org/article/3119670e84aa4bd090144ed5b5749305
Autor:
Shuang Bai, Shanshan Zhou, Junnan Zhang, Weixin Chen, Min Lv, Jian Wang, Ao Zhang, Jiang Wu, Wei Zhao
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundConcomitant administration of COVID-19, influenza, and pneumococcal vaccines could reduce the burden on healthcare systems. However, the immunogenicity and safety of various combinations of a third booster dose of SARS-CoV-2 inactivated vac
Externí odkaz:
https://doaj.org/article/0131df7e610f42f8b1fc8bb700b17b87
Autor:
SeyedAhmad SeyedAlinaghi, Mohsen Dashti, Arian Afzalian, Haleh Siami, Afsaneh Ghasemzadeh, Sanaz Varshochi, Sahar Nooralioghli Parikhani, Masoomeh Fathi Amrollah, Anahid Nourian, Esmaeil Mehraeen, Omid Dadras
Publikováno v:
Preventive Medicine Reports, Vol 44, Iss , Pp 102778- (2024)
Introduction: This study examines the efficacy and safety of three COVID-19 booster vaccines including mRNA-based vaccines (BNT162b2 (BioNTech/Pfizer) and/or mRNA-1273 (Moderna)), Non-Replicating Viral-Vector vaccines (ChAdOx1 nCoV-19 vaccine (AstraZ
Externí odkaz:
https://doaj.org/article/5f078685fbdb48aa87bb18931cfb2bf5